Last updated: April 22, 2026

Application No. 19/179,878

Untitled Application

Unknown

Filed

1600

Priority

Nov 03, 2022 — provisional 63/422,369 +3 more

Examiner

GALSTER, SAMUEL LEONARD

Art Unit

1693

Tech Center

AVILAR THERAPEUTICS, INC.

Assignee

Avilar Therapeutics Inc.

OA Round

1 (Non-Final)

This examiner grants 54% of cases after interview

— +38.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 101 resolved cases, 2023–2026

Examiner Intelligence

GALSTER, SAMUEL LEONARD View full profile →

Grants 54% of resolved cases

Career Allowance Rate

55 granted / 101 resolved

-5.5% vs TC avg

Strong +39% interview lift

Without

With

+38.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

54 currently pending

Career history

155

Total Applications

across all art units

Statute-Specific Performance

§101

1.4%

-38.6% vs TC avg

§103

37.9%

-2.1% vs TC avg

§102

16.8%

-23.2% vs TC avg

§112

25.8%

-14.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 101 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/776,343

Patent 12600743

METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND

3y 11m to grant Granted Apr 14, 2026

17/837,198

Patent 12599611

METHODS AND COMPOSITIONS FOR TREATING SEIZURE DISORDERS IN PEDIATRIC PATIENTS

3y 10m to grant Granted Apr 14, 2026

17/415,274

Patent 12583880

SEPARATION OF OLIGOSACCHARIDES

4y 9m to grant Granted Mar 24, 2026

17/421,880

Patent 12582670

LIGNIN SOLVATION USING AQUEOUS BIOLOGICALLY COMPATIBLE BUFFERS

4y 8m to grant Granted Mar 24, 2026

18/921,816

Patent 12558366

BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF

1y 4m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

54%

Grant Probability

93%

With Interview (+38.7%)

3y 2m

Median Time to Grant

Low

PTA Risk

Based on 101 resolved cases by this examiner. Grant probability derived from career allowance rate.